coseva advanced glutathione Liposomal with Phospholipid Complex coseva advanced glutathione Codeage Liposomal

In a phase 2 trial of obese subjects, cagrilintide used in different subcutaneous doses once weekly was associated with a mean weight loss of 6-10.8% after 26 weeks, compared with 9.0% with the glucagon-like 1 receptor (GLP-1R) liraglutide (3 mg/d) and 3% with placebo at 26 weeks

Description BPC-157 TB-500 blend PSPeptides dual-peptide regenerative research formulation combining 10mg BPC-157 and 10mg TB-500 (Thymosin Beta-4 fragment) in a single lyophilized vial

Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin

Over time, this can lead to clearer, healthier, and more resilient skin

As a next-generation triple-agonist peptide, retatrutide simultaneously targets three critical hormone receptors: GLP-1 (Glucagon-Like Peptide-1), GIP (Gastric Inhibitory Polypeptide), and glucagon receptors